- Home
- LAUR vs IRTC Comparison
LAUR vs IRTC Comparison
Compare LAUR & IRTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LAUR
- IRTC
- Stock Information
- Founded
- LAUR 1989
- IRTC 2006
- Country
- LAUR United States
- IRTC United States
- Employees
- LAUR N/A
- IRTC N/A
- Industry
- LAUR Other Consumer Services
- IRTC Medical/Dental Instruments
- Sector
- LAUR Real Estate
- IRTC Health Care
- Exchange
- LAUR Nasdaq
- IRTC Nasdaq
- Market Cap
- LAUR 2.9B
- IRTC 3.1B
- IPO Year
- LAUR 2017
- IRTC 2016
- Fundamental
- Price
- LAUR $22.80
- IRTC $138.59
- Analyst Decision
- LAUR Buy
- IRTC Strong Buy
- Analyst Count
- LAUR 2
- IRTC 10
- Target Price
- LAUR $20.50
- IRTC $129.90
- AVG Volume (30 Days)
- LAUR 799.0K
- IRTC 521.2K
- Earning Date
- LAUR 05-01-2025
- IRTC 05-01-2025
- Dividend Yield
- LAUR N/A
- IRTC N/A
- EPS Growth
- LAUR 143.51
- IRTC N/A
- EPS
- LAUR 1.90
- IRTC N/A
- Revenue
- LAUR $1,527,432,000.00
- IRTC $618,587,000.00
- Revenue This Year
- LAUR $2.07
- IRTC $17.46
- Revenue Next Year
- LAUR $6.82
- IRTC $16.93
- P/E Ratio
- LAUR $12.05
- IRTC N/A
- Revenue Growth
- LAUR 1.26
- IRTC 20.54
- 52 Week Low
- LAUR $13.60
- IRTC $55.92
- 52 Week High
- LAUR $23.05
- IRTC $128.52
- Technical
- Relative Strength Index (RSI)
- LAUR 73.64
- IRTC 82.03
- Support Level
- LAUR $19.71
- IRTC $103.16
- Resistance Level
- LAUR $23.06
- IRTC $140.73
- Average True Range (ATR)
- LAUR 0.61
- IRTC 4.69
- MACD
- LAUR 0.34
- IRTC 3.67
- Stochastic Oscillator
- LAUR 96.03
- IRTC 94.72
About LAUR Laureate Education Inc.
Laureate Education Inc is an international community of universities. The company provides higher education programs and services to students through an international network of licensed universities and higher education institutions. Its geographical segments include Peru and Mexico.
About IRTC iRhythm Technologies Inc.
iRhythm Technologies Inc is a digital healthcare company that creates trusted solutions that detect, predict, and prevent disease. Its principal business is the design, development, and commercialization of device-based technology to provide ambulatory cardiac monitoring services that it believes allow clinicians to diagnose certain arrhythmias quicker and with greater efficiency than other services that rely on traditional technology. Each Zio System combines an FDA-cleared and CE-marked, wire-free, patch-based, 14-day wearable biosensor that continuously records electrocardiogram (ECG) data with a proprietary, FDA-cleared, CE-marked cloud-based data analytic software to help physicians monitor patients and diagnose arrhythmias.